The US FDA buying baby heads to “humanize mice”? Sounds like horrible science fiction, but it’s reality.
Judicial Watch recently revealed that it obtained 198 pages of documents and communications from the U.S. Food and Drug Administration (FDA) including discussion of “humanized mice”, the study of human fetal organs, aborted tissue and even baby HEADS! The evidence also includes communications and even written agreements with human fetal tissue provider Advanced Bioscience Resources (ABR). Most of the documents are communications. Relevant attachments sent between Perrin Larton, a purchase supervisor for ABR, and research veterinary medical officer Dr. Kristina Howard of the FDA.
Everything appearing in bold provided by Judicial Watch
Judicial Watch got the documents via a March 2019 Freedom of Information Act (FOIA) lawsuit against the U.S. Department of Health and Human Services, of which the FDA is a part.
Tired of Ads? Subscribe or Donate!
The claim requests all written agreements and any related documents on disbursement of funds, documentation of technical procedure as well as interactions in between the FDA and the ABR for the arrangement of human fetal tissue to be made available for use in a humanized mice study. After successfully opposing the FDA’s redaction of particular info from its documents, a federal court ordered HHS to provide extra details regarding its acquisitions of organs collected from aborted human fetuses– including “line item prices,” or the rate per body part the government paid to ABR. The court likewise noted that “there is reason to question” whether these transactions breach laws that ban the sale of fetal body body parts and organs. Documents previously revealed in this suit show the government demanded the baby body parts be “fresh and never frozen.”
The documents include an FDA generated agreement with ABR, based on a “requisition” it provided on July 27, 2012, for $12,000 worth of “tissue procurement for humanized mice,” shows the deal was for a “non-competitive honor.” The preliminary honor was for $12,000, the complete projected quantity of funds set aside for the deal was $60,000. Under “Justification for Other than Full and Open Competition,” the FDA said:
Scientists within the FDA and in the larger field of humanized mouse (HM) research have searched extensively over the past several years and ABR is the only company in the U.S. capable of supplying tissues suitable for HM research. No other company or organization is capable of fulfilling the need.
FETAL CADAVEROUS PROCUREMENT SERVICE FEE
The HM [humanized mice] are created by surgical implantations of human tissue into mice that have multiple genetic mutations that block the development of the mouse immune system at a very early stage. The absence of the mouse immune system allows the human tissues to grow and develop into functional human tissues…. In order for the humanization to proceed correctly we need to obtain fetal tissue with a specific set of specialized characteristics.
The records include a record of demands by the FDA for “Payment by Electronic Funds Transfer,” in which ABR must follow regulations en regards to “Convict Labor” as well as “Child Labor-Cooperation with Authorities and Remedies.” On September 24, 2018, the Trump FDA ended their agreement with ABR for body part sales then began an audit of its acquisitions of infant body parts. The documents include the FDA’s letter terminating the contract:
Based on the terms and conditions of the Purchase Order as awarded to Advanced Bioscience Resources, Inc. (“ABR”) on July 27, 2018, the Government is not sufficiently assured that the human tissue provided to the Government to humanize the immune systems of mice will comply with the prohibitions set forth under 42 U.S.C. § 289g- 2. Furthermore, the Government has concerns with the sufficiency of the sole-source justification. Therefore, pursuant to FAR [Federal Acquisition Regulation] clause 52.213-4(f), the Purchase Order is being terminated effective September 24, 2018.
“Chopping up aborted human beings for their organs and tissue is a moral and legal outrage,” said Judicial Watch President Tom Fitton. “This issue should be front and center in any debate about America’s barbaric abortion industry.”
In February 2020, Judicial Watch first discovered with this suit numerous pages of documents from the National Institutes of Health (NIH) that exposed how the NIH paid thousands of taxpayer dollars to a California-based firm in order to purchase organs from aborted human beings! They used unborn children to create “humanized mice”. Sounds like an abomination.
In May 2021, Judicial Watch’s legal action exposed FDA documents revealing how the agency invested 10’s of thousands in taxpayers money to get aborted human fetal tissue from ABR. The cells were then used in developing “humanized mice” to check “biologic drug products.” The documents demanded the FDA be delivered cells “Fresh; shipped on wet ice.”
Tired of Ads? Subscribe or Donate!
August 3, 2021, Judicial Watch announced that they, along with The Center for Medical Progress (CMP), through a different legal action, obtained 252 pages of even more new records from the U.S. Department of Health and Human Services that reveal virtually $3 million in government funds were spent on the University of Pittsburgh’s pursuit to end up being a “Tissue Hub” for human fetal cells varying from 6 to 42 weeks’ pregnancy. Pitt’s target objective “is to have available a minimum of 5 situations (tissues and if possible various other biologicals) per week of gestational age for ages 6-42 weeks.”.
Using the globalists own tactics against them.